Lucid Diagnostics Inc. (LUCD) stock
LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3078% above fair value
$0.45+0.03 (+7.88%)
Close on Nov 13, 2026Market cap $91.28MP/E –Yield –
Lucid Diagnostics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Lucid Diagnostics's enterprise value was $39.35M on Nov 11, 2026, against $91.45M a year earlier. Over the last 5 years it ranged from $12.51M to $154.08M, with a median of $38.60M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $39.35M | -58.7% |
| 2025 | Dec 31, 2025 | $95.38M | +243.6% |
| 2024 | Dec 31, 2024 | $27.75M | -22.1% |
| 2023 | Dec 29, 2023 | $35.64M | +52.2% |
| 2022 | Dec 30, 2022 | $23.41M | -69.1% |
| 2021 | Dec 31, 2021 | $75.77M | – |
See a number that looks wrong?